The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...
Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...
Agency commissioners voted unanimously on Tuesday to publish the report, which makes a similar attack on the drug middlemen ...
CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal ...
On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...
Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...
The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...
Margin expansion at Express Scripts, Caremark and Optum Rx increased by $336 million between 2017 and 2021, officials say.
WASHINGTON >> The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback